Description: This session is about regulatory constraints and the role the NAIC is playing to help facilitate 24-hour programs, plan design issues, the use of managed care, coverage as part of a workers' compensation plan versus coverage of health care outside of the workers' compensation system. From Record of Society of Actuaries Vol. 18, No. 4A.

Description: Artificial intelligence (AI) at the heart of new digital tools allows actuaries to extract structured data useful for creating more precise risk assessment models. This technology sits best alongside the expertise of insurance professionals who have years of experience in the industry. RGA’s partnership with DigitalOwl is an example of how AI combines with human knowledge for the best outcomes.

Description: This article covers the results of the elections for the 2013 product development section council. In particular, it gives the background on the following individuals who were newly elected to a 3-year term on the council: Vera Ljucovic, Jim Filmore, and Joe Kordovi. It also gives the background on Dave Moran who was chosen by the council for a 1-year term to replace a council member that had to step down prior to completing their 3-year term.

Description: Panelists discuss pricing issues regarding supplemental products, which for this purpose, are defined as cancer, specified disease, student accident, and other special risk accident and health coverages. From the Record of the Society of Actuaries, Vol. 25, No. 2.

Description: Description and welcome to the 2020 Canadian Reinsurance Conference including highlight of the key note speaker

Description: This article contains a summary of some of the presentations given at the October 2012 SOA Annual Meeting. This article does not cover all sessions that are related to product development, but shares observations that have been made by various members of the SOA Product Development Section Council.

Description: Highlights of the Actuary of the Future Section and the Product Development Section

Description: The presenters describe the process payers and employers can use to evaluate emerging medical device technologies, recent or pending FDA submissions for prescription drugs and experimental treatments that impact patient care, resource utilization and health care expenditures. Learn the process of identifying and selecting impactful treatments (Horizon Scanning) and quantifying the financial cost of new technologies before they arrive in the market. These workflows can be leveraged by actuaries, healthcare economists, clinicians and pharmacists from a payer (Commercial and Medicare) and employer perspective for self-funded plans. Walk through sample models that illustrate how costs for emerging technologies and treatments can be modeled.

Description: Overview of the diverse Asia markets and four key themes:Rapid pace of product development, innovative underwriting solutions, Wellness, the rise of insurtech.

Description: Our goal in this article is to dive deeper into the role longevity swaps could play in the US PRT market by drawing comparisons to the UK and highlighting recent commercial developments that can jump start the US market’s need for longevity reinsurance.